BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meroni G, Desagher S. Cellular Function of TRIM E3 Ubiquitin Ligases in Health and Disease. Cells 2022;11:250. [DOI: 10.3390/cells11020250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumarasinghe L, Garcia-Gimeno MA, Ramirez J, Mayor U, Zugaza JL, Sanz P. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease. Neurobiol Dis 2023;177:105998. [PMID: 36638890 DOI: 10.1016/j.nbd.2023.105998] [Reference Citation Analysis]
2 Palomba T, Tassone G, Vacca C, Bartalucci M, Valeri A, Pozzi C, Cross S, Siragusa L, Desantis J. Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design. Int J Mol Sci 2022;23. [PMID: 36430693 DOI: 10.3390/ijms232214218] [Reference Citation Analysis]
3 Zhang Y, Zhang W, Zheng L, Guo Q. The roles and targeting options of TRIM family proteins in tumor. Front Pharmacol 2022;13:999380. [DOI: 10.3389/fphar.2022.999380] [Reference Citation Analysis]
4 Yang E, Huang S, Jami-alahmadi Y, Mcinerney GM, Wohlschlegel JA, Li MMH. Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes. PLoS Pathog 2022;18:e1010743. [DOI: 10.1371/journal.ppat.1010743] [Reference Citation Analysis]
5 Lu Y, Xiao Y, Yang J, Su H, Zhang X, Su F, Tian B, Zhao D, Ling X, Zhang T, Roy S. TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/4374978] [Reference Citation Analysis]
6 Yang E, Huang S, Jami-alahmadi Y, Mcinerney GM, Wohlschlegel JA, Li MM. Substrate trapping approach identifies TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes.. [DOI: 10.1101/2022.03.17.484727] [Reference Citation Analysis]